UROGIV Research Group, Department of Surgery, School of Medicine, Universidad del Valle, Cll 4B #36-00, Cali, Colombia.
Division of Urology/Urooncology, Department of Surgery, School of Medicine, Universidad del Valle, Cali, Colombia.
Int Urol Nephrol. 2024 Jan;56(1):1-7. doi: 10.1007/s11255-023-03753-4. Epub 2023 Sep 12.
Prostate cancer is one of the tumors with the highest incidence and mortality among men worldwide, and this situation is no different in South America. However, epidemiological data are highly variable for each country and even more so than in North America. These data may be influenced by the very low rate of early detection of disease, availability of diagnostic methods, proper data collection, and limited access to specialized multidisciplinary treatment. For many South American countries, academic referral centers can only offer state-of-the-art diagnostics and multidisciplinary cancer treatment for patients who live in or can travel to large cities, so most patients are cared for by non-expert urologists with limited resources, which can have a negative impact on their prognosis and worsen oncologic outcomes. We aimed to show the clinical management of prostate cancer patients, the current advances in management, limitations present in South America, and how a multidisciplinary approach in referral cancer centers conformed of specialized urologists, medical oncologists, and mental health professionals can maximize patient outcomes.
前列腺癌是全球男性中发病率和死亡率最高的肿瘤之一，这种情况在南美洲也不例外。然而，每个国家的流行病学数据差异很大，甚至比北美还要大。这些数据可能受到疾病早期检测率低、诊断方法的可用性、正确的数据收集以及获得专门的多学科治疗的机会有限等因素的影响。对于许多南美国家来说，学术转诊中心只能为居住在或能够前往大城市的患者提供最先进的诊断和多学科癌症治疗，因此大多数患者由资源有限的非专家泌尿科医生治疗，这可能对他们的预后产生负面影响，并导致肿瘤学结果恶化。我们旨在展示前列腺癌患者的临床管理、管理方面的当前进展、南美洲存在的局限性，以及由专业泌尿科医生、肿瘤内科医生和心理健康专业人员组成的多学科转诊癌症中心如何最大限度地提高患者的治疗效果。
